Alcon Stock Gains From CMS Decision, New Products – MDDI Index
This article was originally published in The Gray Sheet
Executive Summary
CMS' decision to expand Medicare coverage to Alcon's AcrySof ReStor intraocular lens enhanced investor confidence in the device and helped push the stock up 22.5% for the second quarter